GlassScriptPhysician profile
Makeba J Burke
NPI 1922436922
$1,070.95
in general payments reported to CMS, 2019-2025
9 companies · $613 in 2025
The $613 reported for 2025 was more than what 75% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.43 · 2023: $196 · 2024: $246 · 2025: $613.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $918 · Education: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $917.51 |
| Education | $137.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $355.60 | 2025 | Krystexxa, Uplizna |
| Astrazeneca Pharmaceuticals LP | $170.82 | 2023 | Farxiga, Breztri |
| Medical Device Business Services, INC. | $137.01 | 2025 | Stratafix |
| Abbvie INC. | $124.96 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $120.02 | 2025 | Xifaxan |
| Neurocrine Biosciences, INC. | $104.99 | 2024 | Ingrezza |
| Merck Sharp & Dohme LLC | $25.03 | 2023 | M-M-R II, Gardasil 9, Vaxelis |
| Alexion Pharmaceuticals, INC. | $16.43 | 2021 | |
| Intuitive Surgical, INC. | $16.09 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Makeba Burke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.